![Diego A. Rey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Diego A.
Rey was the Chief Technology Officer of GeneWeave Biosciences, Inc. which was founded in 2007.
Mr. Rey is also the founder of Endpoint Health, Inc.
Diego A. Rey active positions
Companies | Position | Start |
---|---|---|
Endpoint Health, Inc.
![]() Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Founder | - |
Former positions of Diego A. Rey
Companies | Position | End |
---|---|---|
GeneWeave Biosciences, Inc.
![]() GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
GeneWeave Biosciences, Inc.
![]() GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Health Services |
Endpoint Health, Inc.
![]() Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Commercial Services |
- Stock Market
- Insiders
- Diego A. Rey